To provide for insurance reform (including health insurance reform), amend title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes.

Issues related to Medicare/Medicaid drug coverage including pharmacy payments (average manufacturer price), reimbursements, competition and plan administration, electronic prescribing, chronic care and PBM disclosure. Issues related to implementation of the Patient Protection and Affordable Care Act including prescription drug coverage, formulary requirements, generic drug co-payments, direct negotiation, Medicaid rebate changes, applying Medicaid rebates in Medicare, closure of Part D coverage gap, retiree drug subsidy, funding/revenues for Health Care Reform, H.R. 3200, S1679 America's Health Future Act, H.R. 3950 Patient Protection and Affordable Care Act. H.R. 4752 - Medicare Prescription Drug Price Negotiation Act of 2010 H.R. 4872 - Health Care and Education Reconciliation Act of 2010 H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009 H.R. 4813 - To provide for insurance reform (including health insurance reform), amend Title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes.

Client expense: $525,828 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Election Commission (FEC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 1204 - Community Pharmacy Fairness Act, Electronic Prescribing, Mail Order and Pharmacy Chronic Care Management H.R. 1706, S369 relating to settlement payments between brand and generic manufacturers, issues related to oversight of pharmacy benefits for federal employee health benefits program, items related to the application of drug benefits to public plans and health exchange, including PBM disclosure in H.R. 3200, S11679 America's Health Future Act, issues related to generic dispensing and study of the impact of state 'carve-out" laws on generic utilization. H.R. 4199 - Patients Health and Real Medication Access Cost Savings Act. H.R. 5234 - PBM Audit Reform and Transparency Act H.R. 4872 - Health Care and Education and Reconciliation Act of 2010 H.R. 4813 - To provide for insurance reform (including health insurance reform) amend Title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes. H.R. 4489 - FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 3950 - Patient Protection and Affordable Care Act

Client expense: $525,828 · Firm income: Not reported

Medicare Patient IVIG Access Act (S. 701) H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, Health Care and Education Reconciliation Act, provisions concerning orphan drugs; H.R. 4813, to provide for insurance reform, provisions concerning orphan drugs.

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of

Medicare Patient IVIG Access Act (S. 701) H.R. 3590, Patient Protection and Affordable Care Act, provisions regarding pharmaceutical fees; H.R. 4872, Health Care and Education Reconciliation Act, provisions concerning Medicaid rebates, orphan drugs; H.R. 4813, to provide for insurance reform, provisions concerning Medicaid rebates, orphan drugs.

Client expense: $70,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE, Treasury, Dept of

Medicare Patient IVIG Access Act (S. 701) H.R. 3590, Patient Protection and Affordable Care Act, provisions regarding pharmaceutical fees; H.R. 4872, Health Care and Education Reconciliation Act, provisions concerning Medicaid rebates, orphan drugs; H.R. 4813, to provide for insurance reform, provisions concerning Medicaid rebates, orphan drugs.

Client expense: $70,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE, Treasury, Dept of

Medicare Patient IVIG Access Act (S. 701) H.R. 3590, Patient Protection and Affordable Care Act, provisions regarding pharmaceutical fees; H.R. 4872, Health Care and Education Reconciliation Act, provisions concerning Medicaid rebates, orphan drugs; H.R. 4813, to provide for insurance reform, provisions concerning Medicaid rebates, orphan drugs.

Client expense: $70,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE, Treasury, Dept of

Issues related to Medicare/Medicaid drug coverage including pharmacy payments (average manufacturer price), reimbursements, competition and plan administration, electronic prescribing, chronic care and PBM disclosure. Health reform proposals impacting prescription drug coverage including formulary requirements, generic drug co-payments, direct negotiation, Medicaide rebate changes, applying Medicaid rebates in Medicare, closure of Part D coverage gap, retiree drug subsidy, funding/revenues for Health Care Reform, H.R. 3200, S1679 America's Health Future Act, H.R. 3950 Patient Protection and Affordable Care Act. H.R. 4752 - Medicare Prescription Drug Price Negotiation Act of 2010 H.R. 4872 - Health Care and Education Reconciliation Act of 2010 H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009 H.R. 4813 - To provide for insurance reform (including health insurance reform), amend Title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes.

Client expense: $644,766 · Firm income: Not reported

Establishing a regulatory approval pathway for biogeneric drugs - H.R. 1427/S726 - Promoting Innovation and Access to Life Saving Medicine Act and H.R. 1548 - Pathway for Biosimilars Act Items related to the application of drug benenfits to public plans and health exchange, including PBM disclosure in H.R. 3000, S169 - America's Health Future Act, H.R. 3962, H.R. 3950 - Patient Protection and Affordable Care Act. H.R. 4872 - Health Care and Education Reconciliation Act of 2010 H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009 H.R. 4813 - To provide for insurance reform (including health insurance reform) amend Title XVIII of the Social Security Act to reform medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes. H.R. 4489 - FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act

Client expense: $644,766 · Firm income: Not reported

H.R. 1204 - Community Pharmacy Fairness Act, Electronic Prescribing, Mail Order and Pharmacy Chronic Care Management H.R. 1706, S369 relating to settlement payments between brand and generic manufacturers, issues related to oversight of pharmacy benefits for federal employee health benefits program, items related to the application of drug benefits to public plans and health exchange, including PBM disclosure in H.R. 3200, S11679 America's Health Future Act, issues related to generic dispensing and study of the impact of state 'carve-out" laws on generic utilization. H.R. 4199 - Patients Health and Real Medication Access Cost Savings Act. H.R. 5234 - PBM Audit Reform and Transparency Act H.R. 4872 - Health Care and Education and Reconciliation Act of 2010 H.R. 4813 - To provide for insurance reform (including health insurance reform) amend Title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes. H.R. 4489 - FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 3950 - Patient Protection and Affordable Care Act

Client expense: $644,766 · Firm income: Not reported

Medicare Patient IVIG Access Act (S. 701); H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, Health Care and Education Reconciliation Act, provisions concerning Medicaid rebates, orphan drugs; H.R. 4813, to provide for insurance reform, provisions concerning Medicaid rebates, orphan drugs.

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of

H.R. 1204 - Community Pharmacy Fairness Act, Electronic Prescribing, Mail Order and Pharmacy Chronic Care Management H.R. 1706, S369 relating to settlement payments between brand and generic manufacturers, issues related to oversight of pharmacy benefits for federal employee health benefits program, items related to the application of drug benefits to public plans and health exchange, including PBM disclosure in H.R. 3200, S11679 America's Health Future Act, issues related to generic dispensing and study of the impact of state 'carve-out" laws on generic utilization. H.R. 4199 - Patients Health and Real Medication Access Cost Savings Act. H.R. 5234 - PBM Audit Reform and Transparency Act H.R. 4872 - Health Care and Education and Reconciliation Act of 2010 H.R. 4813 - To provide for insurance reform (including health insurance reform) amend Title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes. H.R. 4489 - FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 3950 - Patient Protection and Affordable Care Act

Client expense: $551,889 · Firm income: Not reported

Issues related to Medicare/Medicaid drug coverage including pharmacy payments (average manufacturer price), reimbursements, competition and plan administration, electronic prescribing, chronic care and PBM disclosure. Health reform proposals impacting prescription drug coverage including formulary requirements, generic drug co-payments, direct negotiation, Medicaide rebate changes, applying Medicaid rebates in Medicare, closure of Part D coverage gap, retiree drug subsidy, funding/revenues for Health Care Reform, H.R. 3200, S1679 America's Health Future Act, H.R. 3950 Patient Protection and Affordable Care Act. H.R. 4752 - Medicare Prescription Drug Price Negotiation Act of 2010 H.R. 4872 - Health Care and Education Reconciliation Act of 2010 H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009 H.R. 4813 - To provide for insurance reform (including health insurance reform), amend Title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes.

Client expense: $551,889 · Firm income: Not reported

Establishing a regulatory approval pathway for biogeneric drugs - H.R. 1427/S726 - Promoting Innovation and Access to Life Saving Medicine Act and H.R. 1548 - Pathway for Biosimilars Act Items related to the application of drug benenfits to public plans and health exchange, including PBM disclosure in H.R. 3000, S169 - America's Health Future Act, H.R. 3962, H.R. 3950 - Patient Protection and Affordable Care Act. H.R. 4872 - Health Care and Education Reconciliation Act of 2010 H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009 H.R. 4813 - To provide for insurance reform (including health insurance reform) amend Title XVIII of the Social Security Act to reform medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes. H.R. 4489 - FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act

Client expense: $551,889 · Firm income: Not reported

H.R. 1204 - Community Pharmacy Fairness Act, Electronic Prescribing, Mail Order and Pharmacy Chronic Care Management H.R. 1706, S369 relating to settlement payments between brand and generic manufacturers, issues related to oversight of pharmacy benefits for federal employee health benefits program, items related to the application of drug benefits to public plans and health exchange, including PBM disclosure in H.R. 3200, S11679 America's Health Future Act, issues related to generic dispensing and study of the impact of state 'carve-out" laws on generic utilization. H.R. 4199 - Patients Health and Real Medication Access Cost Savings Act. H.R. 5234 - PBM Audit Reform and Transparency Act H.R. 4872 - Health Care and Education and Reconciliation Act of 2010 H.R. 4813 - To provide for insurance reform (including health insurance reform) amend Title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes. H.R. 4489 - FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 3950 - Patient Protection and Affordable Care Act

Client expense: $551,889 · Firm income: Not reported

Establishing a regulatory approval pathway for biogeneric drugs - H.R. 1427/S726 - Promoting Innovation and Access to Life Saving Medicine Act and H.R. 1548 - Pathway for Biosimilars Act Items related to the application of drug benenfits to public plans and health exchange, including PBM disclosure in H.R. 3000, S169 - America's Health Future Act, H.R. 3962, H.R. 3950 - Patient Protection and Affordable Care Act. H.R. 4872 - Health Care and Education Reconciliation Act of 2010 H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009 H.R. 4813 - To provide for insurance reform (including health insurance reform) amend Title XVIII of the Social Security Act to reform medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes. H.R. 4489 - FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act

Client expense: $551,889 · Firm income: Not reported

Issues related to Medicare/Medicaid drug coverage including pharmacy payments (average manufacturer price), reimbursements, competition and plan administration, electronic prescribing, chronic care and PBM disclosure. Health reform proposals impacting prescription drug coverage including formulary requirements, generic drug co-payments, direct negotiation, Medicaide rebate changes, applying Medicaid rebates in Medicare, closure of Part D coverage gap, retiree drug subsidy, funding/revenues for Health Care Reform, H.R. 3200, S1679 America's Health Future Act, H.R. 3950 Patient Protection and Affordable Care Act. H.R. 4752 - Medicare Prescription Drug Price Negotiation Act of 2010 H.R. 4872 - Health Care and Education Reconciliation Act of 2010 H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009 H.R. 4813 - To provide for insurance reform (including health insurance reform), amend Title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes.

Client expense: $551,889 · Firm income: Not reported

H.J. Res 45, Medicare physician payment reform of the Sustainable Growth Rate, Prevent Medicare physician pay cuts H.R.1585, Fitness Integrated with Teaching Kids Act, Understanding the role of local primary care physicians in obesity prevention H.R. 2249, Health Care Price Transparency Promotion Act of 2009, Determining pricing information that clarifies primary care's practices H.R. 3961, Statutory Pay-As-You-Go Act of 2009, Postponing the Medicare payment cuts until September 30, 2010 H.R. 3962, Affordable Health Care for America Act, Title VII primary care medicine training grants program to provide a 2.2 percent update in payments H.R. 4213, American Workers, State, and Business Relief Act of 2010, Postponing the Medicare physician pay cuts until September 30, 2010, preventing 21 percent reduction in Medicare's payments to physicians and extending the enhanced FMAP until June 30, 2011 H.R. 4700, Transparency in All Health Care Pricing Act of 2010, Determining pricing information that clarifies primary care's practices H.R. 4803, To ensure health care consumer and provider access to certain health benefits plan information and to amend title XIX of the Social Security Act to provide transparency in hospital price and quality information, Determining pricing information that clarifies primary care's practices H.R. 4813, To provide for insurance reform (including health insurance reform), amend title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes, Postponing the Medicare physician pay cuts until September 30, 2010 H.R. 4851, Continuing Extension Act of 2010, Prevent Medicare physician pay cuts H.R. 5690, To improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system, and for other purposes, AAFP policy supports medical liability reforms S. 1628, Rural Physician Pipeline Act of 2009, Health professions training funds and rural health needs S. 1681, Health Insurance Industry Antitrust Enforcement Act of 2009, Health professions training funds and rural health needs S. 3217, Restoring American Financial Stability Act of 2010, Repealing the federal antitrust exemption for health insurance companies to give primary care physicians the ability to negotiate their fees. No Bill Number, President's budget for HHS programs, AAFP federal budget priorities-Title VII Sec 747 grants, NHSC, AHRQ, Rural Health Programs No Bill Number, FY 2011 appropriations for AHRQ to provide for the President's budget request of $611 million plus the new Primary Care Extension program authorized at $120 million, AHRQ comparative effectiveness research, health information technology support and practice enhancement and support No Bill Number, Increased FY 2011 appropriations for Title VII section 749B Rural physician training grants authorized by health reform law No Bill Number, Increased health professions grants for addressing unique health service needs for rural communities No Bill Number, Increased FY 2011 appropriations for Title VII health professions grants for primary care funding, Title VII Sec 747 primary care training grants program No Bill Number, Increased FY 2011 funding for the new Title VII health Teaching Health Centers Development grants authorized by health reform, Promoting a new model of training for primary care physicians in health centers No Bill Number, Increased FY 2011 appropriations for National Health Service Corp, health care for all medical student debt relief No Bill Number, Funding for National Health Care Workforce Analysis in FY 2011, AAFP workforce policy calls for national health care workforce commission No Bill Number, Antibiotic Resistance, Preventing excessive and unnecessary use of antibiotics No Bill Number, Accountable Care Organizations, Caution re exclusions, patient freedom of choice No Bill Number, Payment Policies under physician fee schedule and other revisions to Part B for FY2011 No Bill Number, Nominations to National Workforce Commission, Securing representation for family medicine No Bill Number, Nominations to Board of Governors of Patient Centered Outcomes Research Institute, Securing representation for family medicine No Bill Number, Nominations to Advisory Group for the prevention, health promotion and integrative and public health, Securing representation for family medicine No Bill Number, To ensure that the Drug Enforcement Administrations regulations are not overly burdensome to small practices No Bill Number, To advocate for small business loans enabling physicians to purchase EHRs and to ensure that MU regulations are not overly burdensome No Bill Number, To discuss educating individuals about the new health care law

H.J. Res 45, Medicare physician payment reform of the Sustainable Growth Rate, Prevent Medicare physician pay cuts H.R. 2249, Health Care Price Transparency Promotion Act of 2009, Determining pricing information that clarifies primary care's practices H.R. 3961, Statutory Pay-As-You-Go Act of 2009, Postponing the Medicare payment cuts until September 30, 2010 H.R. 3962, Affordable Health Care for America Act, Title VII primary care medicine training grants program to provide a 2.2 percent update in payments H.R. 4213, American Workers, State, and Business Relief Act of 2010, Postponing the Medicare physician pay cuts until September 30, 2010, preventing 21 percent reduction in Medicare's payments to physicians and extending the enhanced FMAP until June 30, 2011 H.R. 4700, Transparency in All Health Care Pricing Act of 2010, Determining pricing information that clarifies primary care's practices H.R. 4803, To ensure health care consumer and provider access to certain health benefits plan information and to amend title XIX of the Social Security Act to provide transparency in hospital price and quality information, Determining pricing information that clarifies primary care's practices H.R. 4813, To provide for insurance reform (including health insurance reform), amend title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes, Postponing the Medicare physician pay cuts until September 30, 2010 H.R. 4851, Continuing Extension Act of 2010, Prevent Medicare physician pay cuts S. 1628, Rural Physician Pipeline Act of 2009, Health professions training funds and rural health needs S. 1681, Health Insurance Industry Antitrust Enforcement Act of 2009, Health professions training funds and rural health needs S. 3217, Restoring American Financial Stability Act of 2010, Repealing the federal antitrust exemption for health insurance companies to give primary care physicians the ability to negotiate their fees. No Bill Number, President's budget for HHS programs, AAFP federal budget priorities-Title VII Sec 747 grants, NHSC, AHRQ, Rural Health Programs No Bill Number, FY 2011 appropriations for AHRQ to provide for the President's budget request of $611 million plus the new Primary Care Extension program authorized at $120 million, AHRQ comparative effectiveness research, health information technology support and practice enhancement and support No Bill Number, Increased FY 2011 appropriations for Title VII section 749B Rural physician training grants authorized by health reform law No Bill Number, Increased health professions grants for addressing unique health service needs for rural communities No Bill Number, Increased FY 2011 appropriations for Title VII health professions grants for primary care funding, Title VII Sec 747 primary care training grants program No Bill Number, Increased FY 2011 funding for the new Title VII health Teaching Health Centers Development grants authorized by health reform, Promoting a new model of training for primary care physicians in health centers No Bill Number, Increased FY 2011 appropriations for National Health Service Corp, health care for all medical student debt relief No Bill Number, Funding for National Health Care Workforce Analysis in FY 2011, AAFP workforce policy calls for national health care workforce commission No Bill Number, Antibiotic Resistance, Preventing excessive and unnecessary use of antibiotics No Bill Number, Accountable Care Organizations, Caution re exclusions, patient freedom of choice No Bill Number, Payment Policies under physician fee schedule and other revisions to Part B for FY2011 No Bill Number, Nominations to Board of Governors of Patient Centered Outcomes Research Institute, Securing representation for family medicine No Bill Number, Nominations to Advisory Group for the prevention, health promotion and integrative and public health, Securing representation for family medicine No Bill Number, To ensure that the Drug Enforcement Administrations regulations are not overly burdensome to small practices No Bill Number, To advocate for small business loans enabling physicians to purchase EHRs and to ensure that MU regulations are not overly burdensome No Bill Number, To discuss educating individuals about the new health care law No Bill Number, Graduate Medical Education modernization to improve financing for Family medicine education and training

Medicare Patient IVIG Access Act (S. 701); H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, Health Care and Education Reconciliation Act, provisions concerning Medicaid rebates, orphan drugs; H.R. 4813, to provide for insurance reform, provisions concerning Medicaid rebates, orphan drugs.

Client expense: $70,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of

Medicare Patient IVIG Access Act (S. 701); H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, Health Care and Education Reconciliation Act, provisions concerning Medicaid rebates, orphan drugs; H.R. 4813, to provide for insurance reform, provisions concerning Medicaid rebates, orphan drugs.

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 4872, Health Care and Education Reconciliation Act of 2010; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4813, to provide insurance reform.

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Establishing a regulatory approval pathway for biogeneric drugs - HR 1427/S726 Promoting Innovation and Access to Life Saving Medicine Act and HR 1548 Pathway for Biosimilars Act Items related to the application of drug benefits to public plans and health exchange, include PBM disclosure in HR 3200, S1679 America's Health Future Act, HR 3962, HR3950 Patient Protection and Affordable Care Act. H.R. 4872 - Health Care and Education Reconciliation Act of 2010 H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009 H.R. 4813 - To provide for insurance reform (including health insurance reform), amend title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes. H.R. 4489 - FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act

Client expense: $676,558 · Firm income: Not reported

HR 1204 - community Pharmacy Fairness Act; Electronic Prescribing; Mail Order and Pharmacy Chronic Care Management HR 1706, S369 relating to settlement payments between brand and generic manufacturers; Issues related to oversight of pharmacy benefits for federal emloyee health benefits program; Items related to the application of drug benefits to public plans and health exchange, including PBM disclosure in HR 3200, S1679 America's Health Future Act, Issues related to generic dispensing and study of impact of state "carve-out" laws on generic utilization, HR4199 Patients Health and Real Medication Access Cost Savings Act H.R. 4872 - Health Care and Education Reconciliation Act of 2010 H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009 H.R. 4813 - To provide for insurance reform (including health insurance reform), amend title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes. H.R. 4489 - FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 3950 - Patient Protection and Affordable Care Act

Client expense: $676,558 · Firm income: Not reported

Issues related to Medicare/Medicaid drug coverage including pharmacy payments (average manufacturer price), reimbursements, competition and plan administration, electronic prescribing, chronic care, PBM disclosure. Health reform proposals impacting prescription drug coverage including formulary requirements, generic drug co-payments, direct negotiation, Medicaid rebate changes, applying Medicaid rebates in Medicare, closure of Part D coverage gap, retiree drug subsidy, funding/revenues for Health Care Reform, HR 3200, S1679 America's Health Future Act, HR 3962, HR3950 Patient Protection and Affordable Care Act. H.R.4752 - Medicare Prescription Drug Price Negotiation Act of 2010 H.R. 4872 - Health Care and Education Reconciliation Act of 2010 H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009 H.R. 4813 - To provide for insurance reform (including health insurance reform), amend title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes.

Client expense: $676,558 · Firm income: Not reported

Issues relating to comprehensive health care reform, insurance reforms, delivery system, expanding coverage for the uninsured, changes to drug benefits offered under FEHBP and increasing health care value. Other specific issues include PBM disclosure requirements, PBM tax, generic drug reimbursement under Medicaid, tax issues, changes to Medicare Part D, generic biologics and prevention & wellness issues. Issues related to potential new privacty breach requirements and the use of patient data. HR 3590 - "The Patient Protection and Affordable Care Act" HR 4872 Health Care and Education Affordability Reconciliation Act HR 4813 - To provide for insurance reform (including health insurance reform), amend title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes

Client expense: $1,984,475 · Firm income: Not reported

HR 3590/HR 3962 Hospital payments/coverage expansion; State based non-gov. coops support; Public option opposition; Health insurance exchanges; Individual mandate; Employer continued participation; Acountable Care Organizations; Coverage issues; HR 4813 - COBRA extension

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Patient IVIG Access Act (S. 701); H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, Health Care and Education Reconciliation Act, provisions concerning Medicaid rebates, orphan drugs; H.R. 4813, to provide for insurance reform, provisions concerning Medicaid rebates, orphan drugs.

Client expense: $60,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE